Myasthenia gravis (MG) is characterized by weakness of skeletal muscles because of a decrease in the number of available acetylcholine receptors at neuromuscular junctions. Anticholinesterase medication is widely used to treat MG, but muscarinic side effects sometimes appear and limit the drug usage. To their knowledge, the authors present the first case of coronary spastic angina quite possibly induced by anticholinesterase medica tion to treat MG. The appearance of coronary spastic angina in the present case is likely mediated through the increase of acethylcholine by anticholinesterase medication.
Get full access to this article
View all access options for this article.
References
1.
Drachman DB: Myasthenia gravis; medical progress. N Engl J Med330:1797-1810, 1994.
2.
Yasue H., Horio Y., Nakamura N., et al: Induction of coronary artery spasm by acethylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation74:955-963, 1986.
3.
Okumura K., Yasue H., Horio Y., et al: Multivessel coronary spasm in patients with variant angina: A study with intracoronary injection of acethylcholine. Circulation77:535-542, 1988.
4.
Sekiya M., Okayama H., Suzuki M., et al: Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: A possible vasospasm of small coronary arteries. A case report. Angiology44:811-815, 1993.
5.
Kugiyama K., Yasue H., Okumura K., et al: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation94:266-272, 1996.
6.
Furchgott RF , Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acethylcholine. Nature288:373-376, 1980.
7.
Egashira K., Inou T., Hirooka Y., et al: Impaired coronary blood flow response to acethylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest91:29-37, 1993.
8.
Zeiher AM, Drexler H., Saurbier B., et al: Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest92:652-662, 1993.
9.
Kleman NS, Lehane DE, Geyer CE, et al: Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med82:566-540, 1987.
10.
Ottervanger JP, Wilson Jhp, Stricker BH Ch: Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature. Eur J Clin Pharmacol53:105-110, 1997.
